Diseases, Conditions, Syndromes

EU drug agency starts evaluating new COVID-19 treatment

The European Union's medicines authority said Thursday that it is evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease.


Novavax asks EU drug regulator to OK its COVID vaccine

The European Union's drug regulator said it received an application from Novavax to authorize the American biotechnology company's coronavirus vaccine, a request that could significantly boost the continent's vaccine supplies ...

Diseases, Conditions, Syndromes

Latvia toughens rules for unvaccinated people

Employers in Latvia are allowed to dismiss employees who refuse to get vaccinated against COVID-19 from Monday, under new rules aimed at taming the pandemic in the EU member state.


Franco-Austrian firm Valneva wins EU COVID jab deal

Franco-Austrian biotech firm Valneva will supply the European Union with as many as 60 million doses of its COVID-19 vaccine under the terms of a deal announced on Wednesday.

Diseases, Conditions, Syndromes

EU drug agency looking at data on Merck's COVID-19 pill

The European Union's medicines agency on Monday began reviewing Merck's COVID-19 treatment pill so that it can swiftly advise national drug authorities in the 27-nation bloc that want to begin using it before it gets official ...

Medical economics

COVID-19: Governments must stop vaccine cost secrecy

Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...

page 2 from 3